A New Class of Peroxisome Proliferator-activated Receptor Agonists with a Novel Binding Epitope Shows Antidiabetic Effects (original) (raw)
Peroxisome Proliferator-Activated Receptors as Superior Targets for Treating Diabetic Disease, Design Strategies - Review Article
Ihab Almasri
Turkish Journal of Pharmaceutical Sciences
View PDFchevron_right
A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Recruits PPARγ-Coactivator-1α, Prevents Triglyceride Accumulation, and Potentiates Insulin Signaling in Vitro
Martine Stihle
Molecular Endocrinology, 2006
View PDFchevron_right
New 2-Aryloxy-3-phenyl-propanoic Acids As Peroxisome Proliferator-Activated Receptors α/γ Dual Agonists with Improved Potency and Reduced Adverse Effects on …
Antonio Lavecchia
Journal of medicinal …, 2009
View PDFchevron_right
Targeting Peroxisome Proliferator-Activated Receptors Using Thiazolidinediones: Strategy for Design of Novel Antidiabetic Drugs
Neelaveni Thangavel
International Journal of Medicinal Chemistry, 2017
View PDFchevron_right
S 26948: a New Specific Peroxisome Proliferator Activated Receptor Modulator With Potent Antidiabetes and Antiatherogenic Effects
Antoine Pilon
Diabetes, 2007
View PDFchevron_right
S 26948 : a new specific peroxisome proliferator-activated receptor 7 modulator with potent antidiabetes and antiatherogenic effects
Antoine Pilon
Diabetes, 2007
View PDFchevron_right
[4-(2H-1,2,3-Benzotriazol-2-yl)phenoxy]alkanoic Acids as Agonists of Peroxisome Proliferator-Activated Receptors (PPARs)
Jean-Charles Fruchart
Chemistry & Biodiversity, 2006
View PDFchevron_right
Design and synthesis of non-TZD peroxisome proliferator-activated receptor γ (PPARγ) modulator
Amrutha Nair
Medicinal Chemistry Research, 2014
View PDFchevron_right
A New Selective Peroxisome Proliferator-Activated Receptor γ Antagonist with Antiobesity and Antidiabetic Activity
Walter Wahli
Molecular Endocrinology, 2002
View PDFchevron_right
Design and Synthesis of N -[(4-Methoxyphenoxy)carbonyl]- N -[[4-[2-(5- methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine [Muraglitazar/BMS-298585], a Novel Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist with Efficacious Glucose and Lipid-Lowering Activities
Rajasree Golla, Ramakrishna Seethala
Journal of Medicinal Chemistry, 2005
View PDFchevron_right
Peroxisome proliferator-activated receptors: Targets for the treatment of metabolic illnesses (Review)
oscar enrique gonzalez guerra
Molecular Medicine Reports, 2008
View PDFchevron_right
New 2-Aryloxy-3-phenyl-propanoic Acids As Peroxisome Proliferator-Activated Receptors α/γ Dual Agonists with Improved Potency and Reduced Adverse Effects on Skeletal Muscle Function
Fernando Mazza
Journal of Medicinal Chemistry, 2009
View PDFchevron_right
PAM-1616, a selective peroxisome proliferator-activated receptor γ modulator with preserved anti-diabetic efficacy and reduced adverse effects
Eunkyung Kim
European Journal of Pharmacology, 2011
View PDFchevron_right
Novel biphenylcarboxylic acid peroxisome proliferator-activated receptor (PPAR) δ selective antagonists
Hiroyuki Miyachi
Bioorganic & Medicinal Chemistry Letters, 2009
View PDFchevron_right
Synthetic and natural Peroxisome Proliferator-Activated Receptor (PPAR) agonists as candidates for the therapy of the metabolic syndrome
W. Li
Expert opinion on therapeutic targets, 2017
View PDFchevron_right
Different binding and recognition modes of GL479, a dual agonist of Peroxisome Proliferator-Activated Receptor α/γ
Letizia Giampietro
Journal of Structural Biology, 2015
View PDFchevron_right
Selective modulators of PPAR activity as new therapeutic tools in metabolic diseases
Balint Balint
Endocrine, metabolic & immune disorders drug targets, 2006
View PDFchevron_right
A new class of non-thiazolidinedione, non-carboxylic-acid-based highly selective peroxisome proliferator-activated receptor (PPAR) γ agonists: Design and synthesis of benzylpyrazole acylsulfonamides
Junichi Sakamoto
Bioorganic & Medicinal Chemistry, 2012
View PDFchevron_right
New 2-(aryloxy)-3-phenylpropanoic acids as peroxisome proliferator-activated receptor α/γ dual agonists able to upregulate mitochondrial carnitine shuttle system gene expression
Antonio Lavecchia
View PDFchevron_right
Covalent Peroxisome Proliferator-activated Receptor Adduction by Nitro-fatty Acids: SELECTIVE LIGAND ACTIVITY AND ANTIDIABETIC SIGNALING ACTIONS
Gustavo Bonacci
Journal of Biological Chemistry, 2010
View PDFchevron_right
Crystal Structure of the Peroxisome Proliferator-Activated Receptor γ (PPARγ) Ligand Binding Domain Complexed with a Novel Partial Agonist: A New Region of the Hydrophobic Pocket Could Be Exploited for Drug Design
giuseppe fracchiolla
Journal of Medicinal Chemistry, 2008
View PDFchevron_right
DESIGN OF NEW PEROXISOME PROLIFERATORS GAMMA ACTIVATED RECEPTOR AGONISTS (PPARγ) VIA QSAR BASED MODELING
Abdul Wadood Siddiqui
Journal of Applied Pharmaceutical Sciences and Research, 2018
View PDFchevron_right
A Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist with a Unique in Vitro Profile and Potent Glucose and Lipid Effects in Rodent Models of Type 2 Diabetes and Dyslipidemia
Isabel Rojo
Molecular Endocrinology, 2005
View PDFchevron_right
P633H, a novel dual agonist at peroxisome proliferator-activated receptors α and γ, with different anti-diabetic effects in db/db and KK-A y mice
Lili Wang
British Journal of Pharmacology, 2009
View PDFchevron_right
Design and synthesis of novel bis-oximinoalkanoic acids as potent PPARα agonists
Suresh Giri
Bioorganic & Medicinal Chemistry Letters, 2010
View PDFchevron_right
Structural Development Studies of Subtype-Selective Ligands for Peroxisome Proliferator-Activated Receptors (PPARs) Based on the 3,4-Disubstituted Phenylpropanoic Acid Scaffold as a Versatile Template
Hiroyuki Miyachi
PPAR Research, 2008
View PDFchevron_right
A peroxisome proliferator-activated receptor γ ligand inhibits adipocyte differentiation
James Lenhard
Proceedings of the National Academy of Sciences, 1999
View PDFchevron_right
Benzisoxazole containing Thiazolidinediones as Peroxisome Proliferator Activated Receptor-γ Agonists : Design , Molecular Docking , Synthesis & anti-diabetic studies
Shriram Purohit
2014
View PDFchevron_right
A novel peroxisome proliferator-activated gamma (PPARγ) agonist, CLX-0921, has potent antihyperglycemic activity with low adipogenic potential
Somesh Sharma
Metabolism, 2003
View PDFchevron_right